OpenVSafe by OpenVAERS
Search V-safe

WWF-14757-71955

3 vaccinations 3 coded responses 19 check-ins 2 free-text entries 3 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
070 / NJ
Registered
2021-02-25
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-01-28
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-25
    Registered in v-safe
  3. 2021-02-25
    Dose 2 — Pfizer-BioNTech
  4. 2021-02-25
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  5. 2021-02-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  6. 2021-02-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  7. 2021-02-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-03-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-03-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-03-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-03-04
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-03-11
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-03-18
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-03-27
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-04-01
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-04-08
    Survey response — day 42, dose 2
    MedDRA: Lymphadenopathy, Pyrexia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Fever 103 Swollen glands
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-08
    Report sent to call center — day 42, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  18. 2021-05-27
    Survey response — 3 months, dose 2
    MedDRA: Dyspnoea, Pyrexia, SARS-CoV-2 test negative — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: In April I had 103 fever and troubles breathingTested neg for covid
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-05-27
    Report sent to call center — 3 months, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  20. 2021-08-26
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  21. 2022-01-28
    Dose 3 — Pfizer-BioNTech
  22. 2022-02-25
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  23. 2022-04-04
  24. 2022-04-29
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  25. 2022-08-04
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  26. 2023-01-30
    Survey response — 12 months, dose 3
    MedDRA: Arthritis, Muscle spasms, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  27. 2023-01-30
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  28. 2023-01-31
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  29. 2023-01-31
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  30. 2023-01-31
    Call successful
    Completed over the phone

Vaccinations

DoseDateManufacturerCo-administered
12021-01-28Pfizer-BioNTech
22021-02-25Pfizer-BioNTech
32022-01-28Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-04-08 Successful
2023-01-31
 Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2021-05-27 Successful
2023-01-31
 Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2023-01-30 Successful
2023-01-31
 Completed over the phone

Free text

Release 7 — day 42, dose 2

2021-04-08

Symptoms: Fever 103 Swollen glands

Release 8 — 3 months, dose 2

2021-05-27

Symptoms: In April I had 103 fever and troubles breathingTested neg for covid

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthritis · · ✓
SDDyspnoea ✓ ✓ ✓
SDLymphadenopathy ✓ ✓ ✓
SDMuscle spasms · · ✓
SDPyrexia ✓ ✓ ✓
SDSARS-CoV-2 test negative ✓ ✓ ✓
SDSARS-CoV-2 test positive · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…